Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 52 Week Randomized, Double-Blind, Multicenter, Mechanistic Study with a 24 Week Open-Label Follow-Up to Evaluate the Effect of AVANDIA ™ on Bone in Postmenopausal Women with Type 2 Diabetes Mellitus
rosiglitazone
AVD111179
NCT00679939
Diabetes Mellitus, Type 2
Phase 4
 
May 2013

Powered by ideaPoint, Inc.